Player FM - Internet Radio Done Right
Checked 5M ago
Προστέθηκε πριν από four χρόνια
Το περιεχόμενο παρέχεται από το Noah Goodson, PhD and Noah Goodson. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Noah Goodson, PhD and Noah Goodson ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Player FM - Εφαρμογή podcast
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
Podcasts που αξίζει να ακούσετε
ΕΠΙΧΟΡΗΓΟΎΜΕΝΟ
<
<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/uncuffed">Uncuffed</a></span>


1 Uncuffed
Uncuffed empowers people in California prisons to tell their own stories. The award-winning collaboration between incarcerated student producers and professional journalists shines light on the human experience of people before, during, and after their prison terms. The new Season 4 is hosted by formerly incarcerated producer Greg Eskridge. https://www.WeAreUncuffed.org
Life Science Today
Σήμανση όλων ότι έχουν ή δεν έχουν αναπαραχθεί ...
Manage series 2833924
Το περιεχόμενο παρέχεται από το Noah Goodson, PhD and Noah Goodson. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Noah Goodson, PhD and Noah Goodson ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
…
continue reading
72 επεισόδια
Σήμανση όλων ότι έχουν ή δεν έχουν αναπαραχθεί ...
Manage series 2833924
Το περιεχόμενο παρέχεται από το Noah Goodson, PhD and Noah Goodson. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Noah Goodson, PhD and Noah Goodson ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
…
continue reading
72 επεισόδια
All episodes
×L
Life Science Today

This week, I have an announcement to make. Find out more at https://LifeScienceTodayPodcast.com About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi/Takeda UniQure & CSL Fog Pharma Merck + Imago About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals Find out more at https://LifeScienceTodayPodcast.com Story References Indivior + Opiant Regeneron + CytomX Rezo Provention About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
More CRISPR data, oncology wins, and a new player in ophthalmology Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Regeneron Viatris + Oyster Point About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others Find out more at https://LifeScienceTodayPodcast.com Story References Sumitovant + Myovant Thermo Fisher + Binding Site Group Astellas & Taysha Agios Vaxctye About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more at https://LifeScienceTodayPodcast.com Story References FDA AbbVie + DJS Roche + Hookipa Kyverna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more at https://LifeScienceTodayPodcast.com Story References DICE Odyssey Fred Hutch Merck (MSD) , Merck Story 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC Find out more at https://LifeScienceTodayPodcast.com Story References Nested Therapeutics Cellarity Replimune Estrella Biopharma About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions Find out more at https://LifeScienceTodayPodcast.com Story References Eisai + Biogen Amylyx Sanofi + Regeneron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more at https://LifeScienceTodayPodcast.com Story References Alnylam , Link 2 , Link 3 Intellia Therapeutics Third Harmonic Bio Galvanize Therapeutics About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more at https://LifeScienceTodayPodcast.com Story References Revance Velocity + MedPharmics Arsenal SpringWorks Link 1 , Link 2 , Link 3 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more at https://LifeScienceTodayPodcast.com Story References Novo + Forma Sanofi Boehringer Ingelheim Arcturus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more at https://LifeScienceTodayPodcast.com Story References Alcon + Aerie Novartis + Sandoz Labcorp + RWJBH About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more at https://LifeScienceTodayPodcast.com Story References Bluebird Endo & Pharmacies Genentech + Jemincare Merck + Orna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer Cerevel Abbott AstraZeneca + Daiichi Sankyo About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more at https://LifeScienceTodayPodcast.com Story References Zymergen + Ginkgo Cassava Teva About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As Find out more at https://LifeScienceTodayPodcast.com Story References ZyVersa Incyte Revolution Frontera CAMP4 ForSight Auron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more at https://LifeScienceTodayPodcast.com Story References Vertex + ViaCyte Theravance Biopharma Merck + Orion Pliant Therapeutics Qiming About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth. Find Out More Dan Agroskin Clinical Research Evolved Noah Goodson, PhD John Reites Kyle Ricketts About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Double acquisition, private money, affordable deals, and a surprising $70M launch Find out more at https://LifeScienceTodayPodcast.com Story References Galapagos + CellPoint + AboundBio Radius Ipsen + Epizyme DEM Bio About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Crohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more at https://LifeScienceTodayPodcast.com Story References AbbVie Third Rock Scholar Rock Kyowa Kirin About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Gene therapy, minor legislation, a $625M series D, and four companies raise $373M. Find out more at https://LifeScienceTodayPodcast.com Story References BlueBird FDA Resilience Corvia , Code , Mineralys , Tessa About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharma Find out more at https://LifeScienceTodayPodcast.com Story References GSK + Affinivax Pfizer – Haleon Regeneron Roche + Repare About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Pox progress, an oncology acquisition, and we look at $360M worth of biotech funding Find out more at https://LifeScienceTodayPodcast.com Story References Chimerix, Emergent , SIGA Merck & Kelun Inceptor , Laekna , Kriya About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
An $11.6B yes, $11.7B delay, drop the A1C with GLP, and a billion bio-bucks Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + Biohaven Regulators Lilly BridgeBio + BMS About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal deal Find out more at https://LifeScienceTodayPodcast.com Story References Zymeworks Phathom Catalyst CenExel Intercept + Advanz About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Pharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle looms Find out more at https://LifeScienceTodayPodcast.com Story References Merck Sanofi J&J ThermoFisher Novo Nordisk Eli Lilly About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Drops for reading, a $220M raise, and an acquisition straight out of the movies Find out more at https://LifeScienceTodayPodcast.com Story References Orasis Reify Blackrock + MindX About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
The FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. Find out more at https://LifeScienceTodayPodcast.com Story References FDA Antares + Halozyme GSK + Sierra Ansa Biotechnologies About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Viral therapies, rare disease approvals, and lab space premiums Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + ReViral Novartis Charles River + Explora Labs About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech belt Find out more at https://LifeScienceTodayPodcast.com Story References Ginkgo Eagle + Acacia Gilead Taysha / Orchard / Silverback About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
$2 billion in capital raises mostly by companies that start with the letter A. Find out more at https://LifeScienceTodayPodcast.com Story References 2seventy Bio Ascendis Apellis Argenx About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Alexion + Chugai Biogen Viatris AbbVie About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more at https://LifeScienceTodayPodcast.com Story References Gilead AstraZeneca + Merck + Myriad DNAnexus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Who owns CRISPR, a collaboration, the classics, and more money for biotech. Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi + Adagene AbbVie + Syndesi Atlas About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Purdue Pharma Amicus SPAC About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more at https://LifeScienceTodayPodcast.com Story References Eli Lilly + Innovent Biologics Agios TC Biopharm Blue Water Vaccines Meihua About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Arcellx Intellia + Rewrite Navitor + Janssen ViiV About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime Find out more at https://LifeScienceTodayPodcast.com Story References Genentech Immunocore Biogen Eli Lilly TenSixteen About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Eleusis Abbvie / Pfizer / Leo UCB + Zogenix Kura GSK - Unilever About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines Find out more at https://LifeScienceTodayPodcast.com Story References Scorpion & AstraZeneca ABL & Sanofi Vertex Cochlear Vaxcyte About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnology Find out more at https://LifeScienceTodayPodcast.com Story References Stryker + Vocera Merck KGaA + Exelead BeiGene Eikon About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
We’ve got a new name, gene therapy buyout, a lion of an approval, and an inescapable spotlight. Find out more at https://LifeScienceTodayPodcast.com Story References Novartis + Gyroscope Leo Biogen Biogen 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new year Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References CSL + Vifor Oracle + Cerner Calliditas Omega About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACs Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References M icrosoft + Nuance Roche + Recursion Heron 1E Alvotech About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Vifor + Sanifit + Inositec Kura Differential Syndrome Takeda Aadi BioCryst USDA About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Top dollar lab notes, lab consolidation, RNA sells, and two new approval areas Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Benchling Labcorp Novo Nordisk BioMarin BioMarin 2 AppliedVR AppliedVR 2 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacy Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Johnson & Johnson Organon Medicare PharmaEssentia Arbor Biotechnologies Glen de Vries About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you there Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Roche - Novartis Alphabet Pfizer Parthenon Antios Mission Bio Section 32 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

This week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research. Danielle Coe Black Women in Clinical Research Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Background Danielle Coe started her career as a lab-based scientist, after learning from a friend about work in clinical research she pivoted her goals. It wasn’t immediate, but she eventually found her way into the industry and has forged a path on the site side clinical research. Through the process she was struck by the lack of women of color. To help decrease this gap and drive diversity through peer-to-peer support, Danielle created Black Women in Clinical Research. The goal? To help other black women start and build careers in clinical research through community support, resume crafting, interview preparation, negation tactics for salary, and more. Danielle carved time out of her busy schedule to share her story. I really appreciate the way she has turned the challenges she faced into a solution for others and her drive to provide practical solutions, not just nice ideas. About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Unique therapies including anti-opioid overdose, ocular implants, fish skin, UV light, digital therapeutics, and the impact of approvals Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-074-1 https://tinyurl.com/Niche-074-2 https://tinyurl.com/Niche-074-3 https://tinyurl.com/Niche-074-4 https://tinyurl.com/Niche-074-5 https://tinyurl.com/Niche-074-6 https://tinyurl.com/Niche-074-7 https://tinyurl.com/Niche-074-8 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
The 26-year pipeline, CMDO divestment, oncology, and movement among COVID19 Therapies Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-073-1 https://tinyurl.com/Niche-073-2 https://tinyurl.com/Niche-073-3 https://tinyurl.com/Niche-073-4 https://tinyurl.com/Niche-073-5 https://tinyurl.com/Niche-073-6 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Less than spiffy SPACs, big brains big money, Malaria buzz, vaccines, tests, series A, and Voyager gets a renewed lease on life Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-072-1 https://tinyurl.com/Niche-072-2 https://tinyurl.com/Niche-072-3 https://tinyurl.com/Niche-072-4 https://tinyurl.com/Niche-072-5 https://tinyurl.com/Niche-072-6 https://tinyurl.com/Niche-072-7 https://tinyurl.com/Niche-072-8 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
$11.5B acquisitions, we play “Who’s on First”, COVID19 therapy news, cancer Vaccines may be on the way, and CAR T for cancer is here to stay Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-071-1 https://tinyurl.com/Niche-071-2 https://tinyurl.com/Niche-071-3 https://tinyurl.com/Niche-071-4 https://tinyurl.com/Niche-071-5 https://tinyurl.com/Niche-071-6 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Double approval, double acquisition, $200M for tests, $200M for prostate robots, $450M for $1B worth of gummies Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-070-1 https://tinyurl.com/Niche-070-2 https://tinyurl.com/Niche-070-3 https://tinyurl.com/Niche-070-4 https://tinyurl.com/Niche-070-5 https://tinyurl.com/Niche-070-6 https://tinyurl.com/Niche-070-7 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 069 – BeiGene, Everest, Takeda, Exelixis, PerkinElmer + BioLegend, Prenetics 9:59
Originally Published as The Niche Podcast BeiGene’s oncology machine, China oncology pipelines, COVID costs, two new FDA approvals, $5B life science merger, and Hong Kong joins US SPAC party Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-069-1 https://tinyurl.com/Niche-069-2 https://tinyurl.com/Niche-069-3 https://tinyurl.com/Niche-069-4 https://tinyurl.com/Niche-069-5 https://tinyurl.com/Niche-069-6 https://tinyurl.com/Niche-069-7 https://tinyurl.com/Niche-069-8 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 068 – Eli Lilly + ProQR, Sanofi + Kadmon, Lycia, BlueBird + 2seventy, Mammoth 10:08
Originally Published as The Niche Podcast $1.5B deal, $1.9B merger, protein degraders get backing, an old bird has new tricks, and another billion-dollar valuation for CRISPR Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-068-1 https://tinyurl.com/Niche-068-2 https://tinyurl.com/Niche-068-3 https://tinyurl.com/Niche-068-4 https://tinyurl.com/Niche-068-5 https://tinyurl.com/Niche-068-6 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast This week, I go on vacation and give you a special bonus interview with Sam Searcy, founder and CEO of CliniStart and former NC State Senator Find out more at https://thenichepod.com Story References https://clinistart.com/ https://www.samsearcy.com/ https://www.linkedin.com/in/samuel-searcy-3462891a4/ Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast The Cassava saga, Reify goes big… too big? Humacyte SPAC, vax news you already know, and a new growth hormone therapy – approved! Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-066-1 https://tinyurl.com/Niche-066-2 https://tinyurl.com/Niche-066-3 https://tinyurl.com/Niche-066-4 https://tinyurl.com/Niche-066-5 https://tinyurl.com/Niche-066-6 https://tinyurl.com/Niche-066-7 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Originally Published as The Niche Podcast Alphabet buys, uncertain futures, new biotech funds, HIF-2a, PD-1, and a China Biotech emerges. Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-065-1 https://tinyurl.com/Niche-065-2 https://tinyurl.com/Niche-065-3 https://tinyurl.com/Niche-065-4 https://tinyurl.com/Niche-065-5 https://tinyurl.com/Niche-065-6 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 064 – Jazz, GreenLight, Thermo Fisher + PPD, AbbVie + Soliton, Eliem, COVID Update 7:36
Originally Published as The Niche Podcast This week, approvals for sleep and seizures across the pond, mRNA finds other SPACs, senior notes for CROs, FTC does a double take, IPOs, and boosters Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-064-1 https://tinyurl.com/Niche-064-2 https://tinyurl.com/Niche-064-3 https://tinyurl.com/Niche-064-4 https://tinyurl.com/Niche-064-5 https://tinyurl.com/Niche-064-6 https://tinyurl.com/Niche-064-7 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast Device acquisitions, rare disease approvals, COVID success stories, and clinical research ups and downs. Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-063-1 https://tinyurl.com/Niche-063-2 https://tinyurl.com/Niche-063-3 https://tinyurl.com/Niche-063-4 https://tinyurl.com/Niche-063-5 https://tinyurl.com/Niche-063-6 https://tinyurl.com/Niche-063-7 https://tinyurl.com/Niche-063-8 https://tinyurl.com/Niche-063-9 https://tinyurl.com/Niche-063-10 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 062 – Allergan + AbbVie, CHOP, Amgen + TeneoBio, Cidara, Viatris + Biocon, SOPHiA, Caribou, Artois 8:58
Originally Published as The Niche Podcast This week, look closer – with drops, controlled gene therapy, acquisitions in antibodies, new antifungals, new biosimilars, and several IPOs Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-061-1 https://tinyurl.com/Niche-061-2 https://tinyurl.com/Niche-061-3 https://tinyurl.com/Niche-061-4 https://tinyurl.com/Niche-061-5 https://tinyurl.com/Niche-061-6 https://tinyurl.com/Niche-061-7 https://tinyurl.com/Niche-061-8 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 061 – Bonus Episode – Interview with Brazen Bio founders Shawn Carbonell and Brent Witgen 29:36
Originally Published as The Niche Podcast In this special bonus episode, Dr. Noah Goodson sits down with biotech founders Dr. Shawn Carbonell and Dr. Brent Witgen to discuss their new founder-friendly biotech incubator Brazen Bio. Find out more at https://thenichepod.com Story References https://wefunder.com/brazenbio/ https://www.linkedin.com/company/brazenbio/ https://www.brazen.bio Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast Sequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaboration Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-060-1 https://tinyurl.com/Niche-060-2 https://tinyurl.com/Niche-060-3 https://tinyurl.com/Niche-060-4 https://tinyurl.com/Niche-060-5 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast Dopamine deals, Merck vaccine approval, Epipen settlements, billions in buildings, and outsized Oncology IPO. Story References https://tinyurl.com/Niche-059-1 https://tinyurl.com/Niche-059-2 https://tinyurl.com/Niche-059-3 https://tinyurl.com/Niche-059-4 https://tinyurl.com/Niche-059-5 https://tinyurl.com/Niche-059-6 https://tinyurl.com/Niche-059-7 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast Muddy waters of data privacy and genetic databases, antibody-drug conjugate approvals, unabetted wild enthusiasm for CROs, and mobile MRIs go public. Story References https://tinyurl.com/Niche-058-1 https://tinyurl.com/Niche-058-2 https://tinyurl.com/Niche-058-3 https://tinyurl.com/Niche-058-4 https://tinyurl.com/Niche-058-5 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About The Niche Podcast Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 057 – Bonus Interview with Dr. Jayne Morgan, Executive Director COVID19 Task Force 37:16
Originally Published as The Niche Podcast Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research. Sponsors https://www.thescopemethod.com Dr. Morgan on LinkedIn https://tinyurl.com/Niche-057-1 Dr. Morgan on Instagram https://tinyurl.com/Niche-057-2 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About The Niche Podcast Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Originally Published as The Niche Podcast Pending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-053-1 https://tinyurl.com/Niche-053-2 https://tinyurl.com/Niche-053-3 https://tinyurl.com/Niche-053-4 https://tinyurl.com/Niche-053-5 https://tinyurl.com/Niche-053-6 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

1 Life Science Today 048 – (Bonus) Interview with Dr. Kalali, co-chair of DTRA and founder of CNS Summit 41:55
Originally Published as The Niche Podcast Welcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a clinical research coalition of the most influential companies in the field to talk about decentralized research and collaborating for our success as an industry. 2:35 – From CRO to CNS Summit 10:30 – Ramping up DTRA 12:29 – The Ramp of Decentralized Trials 15:50 – What will stick after the pandemic? 19:28 – How different are decentralized trials really? 22:42 – Technology traps and Hybrid Trials 25:12 – How are trust networks changing with decentralized trials? 29:09 – What is the roll of DTRA in the industry? 33:28 – Ecosystems are interconnected, how can we partner within the clinical research/pharma ecosystem? 36:10 – What is the future of the DTRA? Subscribe@ https://thenichepod.com Sponsors https://www.thescopemethod.com Story References https://cnssummit.org https://dtra.org https://www.linkedin.com/in/amirkalali/ The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.…
L
Life Science Today

Originally Published as The Niche Podcast This is our March bonus episode. I sit down with Dr. Benjamin Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare cost, and how you can get involved in the space. Sponsors https://www.thescopemethod.com Guest References https://www.benschwartzmd.com/ https://www.linkedin.com/in/ben-schwartz-md/ Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
L
Life Science Today

Originally Published as The Niche Podcast Mergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-041-1 https://tinyurl.com/Niche-041-2 https://tinyurl.com/Niche-041-3 https://tinyurl.com/Niche-041-4 Music by Luke Goodson https://www.soundcloud.com/lukegoodson Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.…
Καλώς ήλθατε στο Player FM!
Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.